13d
MyChesCo on MSNNew Survey Sheds Light on Guillain-Barré Syndrome ChallengesThe GBS | CIDP Foundation International has unveiled survey data that paints a sobering picture of the physical, social, and ...
One type, the immune-mediated demyelinating neuropathies, includes Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), multifocal motor neuropathy (MMN), and ...
CONSHOHOCKEN, Pa., Feb. 28, 2025 /PRNewswire/ -- The GBS | CIDP Foundation International today released new survey data illustrating how people with Guillain-Barré Syndrome experience this life ...
The biotech put the message out in a direct-to-consumer TV ad that paints Vyvgart Hytrulo as a drug that can help people with chronic inflammatory demyelinating polyneuropathy (CIDP) live life to ...
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a progressive or relapsing neuropathy likely caused by an autoimmune attack on the peripheral nerves. A number of treatment ...
Senators Tillis and Kelly introduce the bipartisan PLASMA Act to ensure affordable access to plasma-based medicines.
Dublin, March 05, 2025 (GLOBE NEWSWIRE) -- The "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering.
Guillain-Barre Syndrome (GBS) is a rare autoimmune disorder in which the body's immune system mistakenly attacks the peripheral nerves, which are responsible for transmitting signals between the ...
The full GBS Patient Registry Report is available here.You can watch recordings of this year's State of the Science meetings here. For more information, please visit www.gbs-cidp.org or contact ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results